Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
PulmoFlow
PulmoFlow
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Kitabis
Tobramycin
2014-12-02
2024-2030
Respiratory tract infections
,
Cystic fibrosis
,
Urinary tract infections
,
Bacterial infections
,
Intraabdominal infections
,
Pseudomonas infections
,
Infectious skin diseases
,
Bacterial eye infections
,
Staphylococcal infections
,
Central nervous system infections
,
Infectious bone diseases
,
Leukemia
,
Septic shock
,
Ulcerative colitis
,
Ankylosing spondylitis
,
Vomiting
,
Nausea
,
Sarcoidosis
,
Thrombocytopenic purpura idiopathic
,
Pulmonary tuberculosis
,
Mycosis fungoides
,
Systemic lupus erythematosus
,
Rheumatic diseases
,
Bursitis
,
Keratitis
,
Allergic rhinitis perennial
,
Thyroiditis
,
Iritis
,
Hypercalcemia
,
Brain edema
,
Pemphigus
,
Addison disease
,
Collagen diseases
,
Dermatitis herpetiformis
,
Rosacea
,
Inflammation
,
Edema
,
Bacterial conjunctivitis
,
Allergic conjunctivitis
,
Viral conjunctivitis
,
Conjunctivitis
Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use